Public Company News

2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results

-     A multi-center phase Ib/III study in China and the United States led by ProfessorBinghe Xu, MD, PhD, Academician of the Chinese Academy of Engineering -     70% of the patients enrolled in phase Ib study were previously treated with CDK4/6 inhibitors  -     Demonstrated a confirmed objecti...

2023-12-11 18:55 1999

Qudian Inc. Reports Third Quarter 2023 Unaudited Financial Results

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company, today announced its unaudited financial results for the quarter endedSeptember 30, 2023. Third Quarter 2023 Financial Highlights: * Total revenues w...

2023-12-11 18:00 3728

Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib

SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a US study ...

2023-12-11 13:30 1926

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety...

2023-12-11 13:14 1906

Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the clinical data of lisaftocl...

2023-12-11 12:56 1560

Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH

* Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B) simultaneously published inThe Lancet Oncology and presented in oral session at the 65th American Society of Hematology Annual Meeting and Ex...

2023-12-10 18:00 2567

WiMi Announced Augmented Reality Dynamic Image Recognition Based on Deep Convolutional Neural Networks

BEIJING, Dec. 8, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that the deep convolutional neural network(DCNN) was used as the core algorithm for image recognition, a...

2023-12-08 21:00 3079

Lanvin Group Holdings Limited to Hold Annual General Meeting on December 21, 2023

NEW YORK, Dec. 8, 2023 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV, the "Company" or "Lanvin Group"), a global luxury fashion group, today announced that it will hold its annual general meeting of the shareholders (the "AGM") virtually through a live webcast and teleconference onDec...

2023-12-08 19:43 4643

President Jokowi Applauds BRI's Empowerment of MSMEs at the UMKM EXPO(RT) BRILIANPRENEUR 2023

JAKARTA, Indonesia, Dec. 8, 2023 /PRNewswire/ -- PT Bank Rakyat Indonesia (BRI) Persero Tbk. (IDX: BBRI)marked its 128th anniversary with the UMKM EXPO(RT) BRILIANPRENEUR 2023, inaugurated by Indonesia's President, Joko Widodo (Jokowi), at theJakarta Convention Center from December 7 to 10. In hi...

2023-12-08 19:42 4775

ChipMOS REPORTS 20.3% YoY INCREASE IN NOVEMBER 2023 REVENUE

HSINCHU, Dec. 8, 2023 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), today reported a 20.3% year over year increase for i...

2023-12-08 19:00 4688

WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating

* Ranked in top 1% of the over 100,000 companies evaluated * Recognized for outstanding performance across all areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement * Seen as a trusted partner by global clients for its strong sustainability commitment SHANGHAI, Dec. 8...

2023-12-08 17:40 4528

Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2023

BEIJING, Dec. 8, 2023 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading mobile social and entertainment platform in China, today announced its unaudited financial results for the third quarter of 2023.    Third Quarter of 2023 Highlights * Net revenues...

2023-12-08 16:25 5517

Kindred Ventures- SK Networks-SoftBank Ventures Asia Present Global AI Forum in Seoul, South Korea.

* 'AI WAVE 2023': Shaping the Future of Industries with AI, Offering a Platform for Investment Insights * Steve Jang and Kanyi Maqubela, Kindred Ventures' Managing Partners, Led the Discussions with the Leading AI Startups from Silicon Valley and Held Fireside Chats with SK Networks and SoftB...

2023-12-08 15:23 6077

PharmaBlock Officially Joins United Nations Global Compact

NANJING, China, Dec. 8, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has officially joined the United Nations Global Compact (UNGC), which not only affi...

2023-12-08 12:37 2308

Infobird Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement

HONG KONG, Dec. 7, 2023 /PRNewswire/ – Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of AI-powered customer engagement solutions in China, today announced that it received a notification letter (the "Notice") from the Listing Qualifications Depar...

2023-12-08 06:00 4207

NWTN Announces Strategic Partnership with China State Construction Engineering Corporation (Middle East)

DUBAi, UAE, Dec. 7, 2023 /PRNewswire/ -- NWTN Inc. (Nasdaq: NWTN), an eco-conscious mobility technology company bringing passenger-centric green premium mobility solutions to the world ("NWTN" or the "Company"), is thrilled to announce a landmark Memorandum of Understanding (MOU) with China State...

2023-12-08 01:23 3409

AMAZFIT LAUNCHES NEW SPECIAL EDITIONS OF AMAZFIT BALANCE, AND PARTNERS WITH NON-PROFIT ONE TREE PLANTED TO SUPPORT REFORESTATION PROJECTS IN EUROPE

MILPITAS, Calif., Dec. 7, 2023 /PRNewswire/ -- Amazfit , a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), a health technology company, has today unveiled four Special Edition colors of the Amazfit Balance. Along with names inspired by the harmon...

2023-12-08 00:00 2954

WiMi Developed Explainable Artificial Intelligence (XAI)-based fNIRS Neuroimage Classification

BEIJING, Dec. 7, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed explainable artificial intelligence (XAI)-based fNIRS neuroimage classification, bring...

2023-12-07 21:00 2532

Canadian Solar's e-STORAGE to Deliver 1,170 MWh DC of Battery Storage Solutions to the Largest Battery Storage Project in the UK

GUELPH, ON, Dec. 7, 2023 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), has been awarded by Copenhag...

2023-12-07 20:00 1992

CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum

NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments...

2023-12-07 19:25 2288
1 ... 326327328329330331332 ... 772